IRIS

Sfoglia per ???browse.type.metadata.subjectIsicrui???  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 329 a 348 di 2.058
Data di pubblicazione Titolo Autore(i) Tipo File
1-lug-1989 Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy Rothstein, J; Mckhann, G; Guarneri, P; Barbaccia, Ml; Guidotti, A; Costa, E Articolo su rivista
18-feb-2014 Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis Rossi, S; Studer, V; Motta, C; Germani, G; Macchiarulo, G; Buttari, F; Mancino, R; Castelli, M; De Chiara, V; Weiss, S; Martino, G; Furlan, R; Centonze, D Articolo su rivista
1-gen-2015 Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis Sancesario, Gm; Schirinzi, T; Anemona, L; Pisani, A; Porzio, O; Sancesario, G; Bernardini, S Articolo su rivista
1-gen-2020 Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients Stampanoni Bassi, M; Drulovic, J; Pekmezovic, T; Iezzi, E; Sica, F; Gilio, L; Gentile, A; Musella, A; Mandolesi, G; Furlan, R; Finardi, A; Marfia, Ga; Bellantonio, P; Fantozzi, R; Centonze, D; Buttari, F Articolo su rivista
10-feb-2016 Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Albanese, M; Zagaglia, S; Landi, D; Boffa, L; Nicoletti, Cg; Marciani, Mg; Mandolesi, G; Marfia, Ga; Buttari, F; Mori, F; Centonze, D Articolo su rivista
10-feb-2016 Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Albanese, M; Zagaglia, S; Landi, D; Boffa, L; Nicoletti, C; Marciani, Mg; Mandolesi, G; Marfia, Ga; Buttari, F; Mori, F; Centonze, D Articolo su rivista
1-gen-2016 Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease Liguori, C; Chiaravalloti, A; Sancesario, G; Stefani, A; Sancesario, G; Mercuri, Nb; Schillaci, O; Pierantozzi, M Articolo su rivista
1-lug-2012 Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients Martorana, A; Esposito, Z; Di Lorenzo, F; Giacobbe, V; Sancesario, G; Bucchi, G; Bonnì, S; Bernardini, S; Sorge, Rp; Sancesario, G; Bernardi, G; Caltagirone, C; Koch, G Articolo su rivista
1-dic-2021 Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis Stampanoni Bassi, M; Nuzzo, T; Gilio, L; Miroballo, M; Casamassa, A; Buttari, F; Bellantonio, P; Fantozzi, R; Galifi, G; Furlan, R; Finardi, A; De Rosa, A; Di Maio, A; Errico, F; Centonze, D; Usiello, A Articolo su rivista
1-gen-2010 Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. Romigi, A; Bar, Im; Placidi, F; Marciani, Mg; Malaponti, M; Torelli, F; Izzi, F; Prosperetti, C; Zannino, S; Corte, F; Chiaramonte, C; Maccarrone, M Articolo su rivista
1-dic-2017 Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. Liguori, C; Olivola, E; Pierantozzi, M; Cerroni, R; Galati, S; Saviozzi, V; Mercuri, Nb; Stefani, A Articolo su rivista
1-gen-1991 CEREBROSPINAL-FLUID ESTRONE IN PSEUDOTUMOR CEREBRI - A CHANGE IN CEREBRAL STEROID-HORMONE METABOLISM Toscano, V; Sancesario, G; Bianchi, P; Cicardi, C; Casilli, D; Giacomini, P Articolo su rivista
1-apr-2001 Cerebrovascular reactivity and subcortical infarctions Cupini, L; Diomedi, M; Placidi, F; Silvestrini, M; Giacomini, P Articolo su rivista
1-mar-1999 Cerebrovascular reactivity in carotid artery occlusion: possible implications for surgical management of selected groups of patients Silvestrini, M; Vernieri, F; Troisi, E; Passarelli, F; Matteis, M; Pasqualetti, P; Rossini, P; Caltagirone, C Articolo su rivista
15-ago-2010 Changes in cerebrovascular reactivity following low-frequency repetitive transcranial magnetic stimulation Sallustio, F; Di Legge, S; Rizzato, B; Stanzione, P; Koch, G Articolo su rivista
1-gen-1998 Changes in functional outcome in inpatient stroke rehabilitation resulting from new health policy regulations in Italy Paolucci, N; Traballesi, N; Gialloreti, N; Pratesi, N; Lubich, N; Antonucci, N; Caltagirone, C Articolo su rivista
1-gen-2011 Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study Bastianello, S; Giugni, E; Amato, M; Tola, M; Trojano, M; Galletti, S; Luccichenti, G; Quarantelli, M; Picconi, O; Patti, F; COGIMUS study, G; Contributor, ; Centonze, D Articolo su rivista
1-gen-1994 Changes in nocturnal sleep and day time somnolence after CBZ administration [MODIFICAZIONI DEL SONNO NOTTURNO E DELLA SONNOLENZA DIURNA DOPO SOMMINISTRAZIONE DI CARBAMAZEPINA] Gigli, G; Diomedi, M; Placidi, F; Maschio, M; Baldinetti, F; Pauri, F; Ciocari, L; Marciani, Mg Intervento a convegno
1-gen-1984 Changes in slow cerebral potentials (CNV) subsequent to midazolam administration. Double-blind study Fattaposta, F; Floris, R; Sanarelli, L; Terribile, P; Tilia, G Articolo su rivista
8-apr-2010 Changes in the characteristics of Alzheimer patients at the first visit in centers for dementia: a 10-year follow-up study Rozzini, L; Vicini Chilovi, B; Riva, M; Rozzini, R; Boffelli, S; Trabucchi, Mm; Padovani, A Articolo su rivista
Mostrati risultati da 329 a 348 di 2.058
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile